Skip to main content
OpenTrials

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,908 public trials 503 recruiting studies
Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Active, Not Recruiting

Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging

NCT06632912

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +12 more
Locations
  • Shanxian Center for Disease Control and Prevention Heze, Shandong, China
  • Liaocheng Center for Disease Control and Prevention Liaocheng, Shandong, China
  • Daiyue District Center for Disease Control and Prevention Tai’an, Shandong, China
View Trial Details
Active, Not Recruiting

HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B

NCT01796457

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • California Pacific Medical Center San Francisco, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • University of Minnesota Plymouth, Minnesota, United States
View Trial Details
Active, Not Recruiting

HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B

NCT01298037

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • California Pacific Medical Center San Francisco, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNα for the Treatment of Hepatitis B

NCT07135349

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Argo Investigative Site Hefei, Anhui, China
  • Argo Investigative Site Beijing, Beijing Municipality, China
  • Argo Investigative Site Sichuan, Chengdu, China
  • Argo Investigative Site Chongqing, Chongqing Municipality, China
View all 18 locations
View Trial Details
Active, Not Recruiting

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

NCT03228667

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +79 more
Locations
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
  • MemorialCare Health System Fountain Valley, California, United States
View all 35 locations
View Trial Details

Related conditions